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Abstract It is widely accepted that regular physical
exercise helps diabetic patients control blood glucose,
reduce cardiovascular risk factors, and prevent other
related complications. In spite of the undoubted
benefits of regular physical exercise, diabetic patients
with chronic complications should be aware of poten-
tial hazards of practicing exercise. To avoid some
harmful consequences of acute exercise, it is necessary
to adopt a vigilant attitude with these risk patients and
to carefully adjust type and intensity of exercise to the
individual situation. This article intends to summarize
and analyze the current literature concerning the
preventive and therapeutic effects of regular exercise
in diabetic patients, pointing out its physiological in-
fluence on blood glucose regulation, and to analyze the
potential risks of acute physical exercise and the pre-
cautions given to patients with a variety of complications.
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Introduction
Diabetes mellitus (DM) constitutes one of the most
widespread health problems in the world, as it is
estimated that its prevalence of 171 million observed
in 2000 will increase to 366 million in the year 2030
[50]. The interactions of environmental and behavioral
factors, such as physical inactivity, obesity, and stress,
with genetic factors seem to be the main reason for the
epidemic character of DM [17, 32]. These factors are
responsible for the alteration in glucose homeostasis
by impaired glucose tolerance, which can result from
pancreatic b cell dysfunction and/or from the increase
of insulin resistance in target tissues [17, 32]. Eighty-
five to 95% of all DM cases are characterized by
glucose intolerance induced by insulin resistance [5, 17,
33]. Independent of its origin, the resultant chronic
hyperglycemia may negatively influence the structure
and function of many organs, particularly the cardio-
vascular, nervous, and renal systems [33]. Heart
disease is the prevailing cause of diabetes-related
deaths, and it could be expected that approximately
50% of all diabetic patients evidencing signs of
nervous system impairment are affected by cardiac
autonomic neuropathy [3, 6, 17, 34].
Exercise is one of the main therapeutic measures to
deal with high blood glucose levels in diabetic patients
[8, 15, 25, 28]. It is believed to control hyperglycemia
through the improvement of peripheral insulin sensi-
tivity particularly in skeletal muscle [22, 38]. In
addition, many studies have also described exercise as
a countermeasure against many abnormalities ob-
served in diabetic patients, such as hyperlipidemia,
hypertension, and a tendency for hypercoagulation [7,
10, 47], which are considered to increase the risk of
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macro- and microvascular complications [21, 46].
These and many other chronic complications of
diabetes mellitus seem to be attenuated by the regular
practice of physical exercise.
Etiological classification and diagnostic criteria of DM
DM is the general designation for a collection of
endocrine disorders with different kinds of pathogen-
esis. The American Diabetes Association and the
World Health Organization (WHO) identified new
classification criteria of diabetes mellitus in 1997. This
classification includes four clinical categories named
Btype I DM,^ Btype II DM,^ Bother specific types of
DM,^ and Bgestational DM^ [30].
Type I diabetes mellitus (also known as insulin-
dependent diabetes mellitus or juvenile diabetes)
mainly results from the destruction of beta cells in
the pancreatic Langerhans_ islets, leading to an insulin
deficiency; the onset of this type is usually at younger
ages and normally requires insulin supplementation
[30, 32]. Type II diabetes mellitus (also known as non-
insulin-dependent diabetes mellitus) could be the
result of inadequate insulin secretion, insulin resis-
tance in peripheral tissues, or excessive hepatic glucose
production [16, 30, 32], which impair glucose tolerance
(hyperglycemia); this variant usually occurs in individ-
uals aged more than 40 years with a family history of
DM, and apart from the genetic predisposition, the
occurrence of this type of disease is correlated with
physical inactivity and being overweight [5, 16, 17, 32].
The category Bother specific types of DM^ consists of
all particular cases of disease where genetic defects are
responsible for beta cell dysfunction (maturity onset
diabetes in youth) or for insulin resistance in target
tissues, and of all DM situations resulting from
endocrinological pathologies or pancreatic dysfunction
induced by drugs/toxics or infections [5]. Gestational
diabetes mellitus occurs during pregnancy and is the
result of a relative insulin deficiency at the last stage of
pregnancy [5].
Patients with type I DM exhibit normal symptoms
and represent about 5 to 10% of all cases of DM; on
the other hand, type II DM constitutes the most
prevalent category of the disease (90%–95%) and
often remains undiagnosed until complications become
symptomatic [5]. Thus, particularly in patients with
type II DM, early detection of the disease allows them
to make lifestyle changes and initiate medical therapy,
which can reduce the appearance of complications.
Considering the higher and constantly increasing
prevalence of type II DM and the great potential of
nonpharmacological measures associated with small
modifications in lifestyle for primary and secondary
disease prevention, the medical community has
granted much attention to this type of DM and has
defined a set of rules for early diagnosis of the disease.
Tests to detect the occurrence of type II DM should
always be considered in subjects who have one or more
of the risk factors for the development of the disease,
as shown in Table 1 [8].
Table 1 Criteria to check for the existence of type II DM in
adults (adapted from the American Diabetes Association [8])
1. Subjects aged more than 45 years
(When normal, the checkup should be repeated every 1–3 years)
2. Occurrence of symptoms like polyuria, polydipsia, and
unexplained weight loss
3. Asymptomatic subjects carrying at least one of the following
risk factors:
3.1. Have a first-degree parent with diabetes
3.2. Overweight or with a BMI >25 kg/m2
3.3. History of impaired glucose tolerance or impaired fasting
glucose in a previous test
3.4. Hypertension (>140/90 mmHg)
3.5. A plasma high density lipoprotein cholesterol level <35 mg/
dl and/or a plasmatic triglyceride level >250 mg/dl
3.6. History of gestational DM or of a newborn child weighing
more than 4.08 kg
3.7. Sedentary lifestyle
3.8. Other clinical conditions associated with insulin resistance,
such as polycystic ovary syndrome and acanthosis nigricans
Table 2 The WHO criteria for DM diagnosis (adapted from Mayfield [30])
Fasting plasma glucose Plasma glucose 2 h after beginning OGTT Casual plasma glucose
mg/dl mmol/l mg/dl mmol/l mg/dl mmol/l
Normal <110 <6.1 <140 <7.75
IFG Q110<126 Q6.1<7.0
IGT Q140<200 Q7.75<11.1
DM Q126 Q7 Q200 Q11.1 >200 >11.1
IFG Impaired fasting glucose, IGT impaired glucose tolerance, DM diabetes mellitus, OGTT oral glucose tolerance test
Causal plasma glucose is defined as the glucose levels measured anytime of the day, regardless of the time passed after the last meal
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According to the WHO recommendations (see
Table 2), a positive outcome in two of the following
tests to be carried out on different days, constitutes the
criteria for diabetes mellitus diagnosis (Fig. 1) [30]: (1)
the existence of suspected symptoms of DM and the
occurrence of plasma glucose levels higher than 200
mg/dl (or 11.1 mmol/l), measured any time of the day
regardless of the time that passed after the last meal;
(2) the occurrence of a fasting plasma glucose level
higher than 126 mg/dl (or 7.0 mmol/l); and (3) a plasma
glucose level higher than 200 mg/dl (or 11.1 mmol/l) 2
h after beginning an oral glucose tolerance test
(OGTT). OGTT is recommended when fasting plasma
glucose levels are between 5.5 and 7.7 mmol/l.
The condition of impaired glucose tolerance (IGT)
is defined when fasting plasma glucose levels are
higher than normal levels but too low to reach the
criteria for DM diagnosis.
Management of type II DM patients
The goal of DM treatment is directed toward glycemic
control, the correction of all metabolic and functional
abnormalities such as dyslipidemia, hypertension, and
obesity, and the control of morbidity and mortality
related with the disease [8]. Apart from medication,
the standard therapeutic procedures for the treatment
of type II DM include correct dietary control and
regular exercise [8, 9, 25, 35]. According to these
authors, the management of each patient should be
individualized and adjusted to age, medical history,
earlier physical activity, eating habits, and sociocultur-
al factors. Especially before starting an exercise
program, a medical examination is necessary to detect
other diseases or diabetic complications that might
represent contraindications.
Glycemic control
Glycemic control is a main objective in DM patients.
Several studies have shown that improved glycemic
control is associated with decreased rates of chronic
complications, such as retinopathy, nephropathy, neu-
ropathy, and cardiovascular diseases [19, 41, 43, 44].
Capillary blood glucose monitored by the patient
himself represents a useful procedure to control
glycemia and to adjust medications or physical activ-
ity/exercise prescriptions. Usually, capillary blood
glucose monitored once a day is important for the
patient to check to prevent asymptomatic hypoglyce-
mia. Glycated hemoglobin (HbA1c) is required to
estimate the mean glycemia over the preceding 2–3
months and must be measured at least twice a year to
determine whether metabolic control is maintained
within a normal range [39]. Thus, HbA1c is useful in
assessing treatment efficiency and in comparing the
result of the patient_s self-reported testing (Table 3).
Fasting plasma glucose OGTT Casual plasma glucose




≥ 126 mg/dl 









- Diabetic medications 
- Diet control 
- Exercise 
- Monitor FBG & HbA1c  
DM
- Diet control 
- Exercise 
- repeat FBG in 6 month Annual 
FBG  
evaluation 
Fig. 1 Guidelines for diagnosis and blood glucose control in type II diabetes mellitus (adapted from Mayfield [30])
Table 3 Parameters used for a glycemic control in type II DM
patients (adapted from the American Diabetes Association [8])
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Health education
Bodyweight less than 120% of the ideal bodyweight
for normal people is recommended for DM and the
main goals of medical nutrition therapy for this disease
are the following [8]: (1) to attain and maintain
metabolic control, stabilizing blood glucose level in
the normal or nearly normal range; (2) to prevent or
reduce complications of diabetes related to the lipid
and lipoprotein profile, which reduces the risk for
macrovascular disease; (3) to prevent and treat chronic
complications of diabetes; and (4) to improve health
through appropriate choice of food, taking into
account personal and cultural preferences.
Diabetic patients should consume between 2,000
and 2,500 calories/day to maintain ideal bodyweight
[28]. Carbohydrates and monosaturated fat should
provide approximately 60–70% of energy intake.
Carbohydrates from whole grains, fruits, vegetables,
and low-fat milk should be included in the diet. Some
carbohydrates such as candy and cookies should be
avoided because they induce a rapid rise in blood
glucose. The average amount of carbohydrates recom-
mended for patients with DM is 40 to 60% of dietary
intake [1, 17]. However, several studies suggest that
the replacement of monosaturated fat by carbohy-
drates can reduce postprandial glycemia and triglycer-
idemia in type II DM patients [20]. Starch with fiber
may slow down glucose absorption. Nonnutritive
sweeteners (low caloric sugar) are safe for diabetic
patients when consumed within the acceptable daily
intake level established by the US Food and Drug
Administration [18]. The maximum acceptable daily
intake of aspartame, acesulfame K, and sucralose are,
50 mg/kg, 15 mg/kg, and 5 mg/kg, respectively [18].
The protein intake of diabetic patients should sustain
15–20% of the total daily energy spent, and at the
moment, there is no evidence suggesting that protein
intake should be modified in patients with normal
renal function. It is assumed that 10% of energy intake
should be derived from fats and cholesterol intake,
constituting approximately 300 mg/day [4].
Physical exercise in diabetic patients
Important sources of energy for living organisms are
carbohydrates and especially glucose, and low blood
glucose can cause loss of consciousness, seizures, and
death. On the other hand, chronically elevated con-
centrations in blood glucose can result in blindness,
renal failure, cardiac and peripheral vascular diseases,
and neuropathy [17]. Therefore, blood glucose con-
centrations should be maintained within narrow limits
to prevent complications. During fasting, the physio-
logical blood concentrations of glucose are maintained
by the liver. In the postprandial state, the rise in blood
glucose concentration stimulates insulin secretion,
which reduces hepatic glucose production and
increases membrane glucose transporters (GLUT) in
peripheral tissues, thus reducing blood glucose [11, 13,
24, 26].
During exercise, and compared to the basal status,
recruited skeletal muscles require four- to fivefold
more energy for contraction, using blood glucose,
muscle glycogen, and fatty acids derived from adipose
tissue as metabolic fuel [37]. Muscle glycogen serves as
the main fuel source during strenuous and short-term
exercise in healthy subjects. When the duration of
exercise is prolonged, muscle energy is predominantly
derived from blood-born glucose and from fatty acids
produced in the adipose tissue [37, 49, 52]. Enhanced
plasma levels of adrenalin, glucagon, cortisol, and
growth hormone promote both an increased glucose
production and a mobilization of fatty acid from
adipose tissue [37, 49, 52]. In addition, gluconeogenesis
maintains glucose homeostasis by synthesizing glucose
from substrates like pyruvate. These changes may
increase fuel supply to the skeletal muscle contraction
during exercise and prevent hypoglycemia as a result
of excessive utilization of glucose by the contracting
muscles.
Physical exercise is a recommended treatment for
patients with type II DM because it enhances the
GLUT4 expression in trained skeletal muscle with a
consequent increase in the glucose transport capacity
[48]. This mechanism may explain the enhanced
sensitivity to insulin observed in physically active DM
patients [11, 13, 16, 22, 24, 26]. Increased mass in
skeletal muscle, enhanced blood flow in muscle,
greater density of insulin receptors, enhanced disposal
of glucose in skeletal muscle, and a reduction in body
fat could also contribute to this insulin sensitivity and
improved glucose tolerance induced by physical train-
ing in DM patients [25, 49].
As mentioned above, the aim of exercise in type II
diabetic patients is to induce acute and chronic
physiological changes, which improve insulin sensitiv-
ity and glucose tolerance [11, 13, 22, 23, 24, 26]. To
maintain glucose homeostasis, glucagon and adrenalin
are released during acute exercise, which increases
hepatic glucose production; simultaneously, the insulin
secretion by pancreatic b cells is reduced [37, 40, 52].
Thus, an increase in glucose utilization during acute
exercise is accompanied by an increase in hepatic
glucose production, an improved insulin sensitivity
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enhancing the binding of insulin to sarcolemmal
receptors, and an increased GLUT4 expression [15].
From a chronic perspective, the improvement in
insulin sensitivity is positively correlated with the
intensity of aerobic endurance training, which is in
accordance with the fact that insulin resistance in type
II diabetic patients is associated with diminished
physical fitness [15]. Regular exercise, combined with
dietary control training, leads to changes in body
composition, namely, a reduction in body fat and an
increase in muscle mass [9, 15]. This association of
dietary control with physical training seems to improve
the glycemic control better than exercise alone [9, 15],
and this assumption offers an explanation to why
obese subjects with type II DM, when compared to
non-obese patients, show no beneficial effects in
insulin sensitivity from training alone [36].
When patients with type II DM participate in
physical training programs, metabolic control is im-
proved, as evidenced for example by a decrease in
serum triglyceride (TG) and very low density lipopro-
tein (VLDL) cholesterol and an increase in high density
lipoprotein cholesterol at rest [2]. However, some
studies have found that middle-aged subjects (age 40–
54 years) who exercise regularly have a better response
in metabolic control when compared to older subjects
(age 57–61 years), perhaps due to different pretraining
levels of metabolic control or to differences in the
intensity of the training program or magnitude of
chronic complications with advanced age [48].
Precautions before starting a training program
Before starting an exercise program, patients should
submit to a medical examination. Because these
patients have an increased risk of coronary artery
disease and silent cardiac ischemia, the examination
should screen the presence of macro- and microvascu-
lar complications that may be worsened during acute
exercise [2, 17, 19, 34, 40, 48]. In general, physical
exercise could be safely performed by patients with
good glycemic control and without any manifested
chronic complications [8]. However, before starting
any training program, a laboratory-graded exercise test
is recommended for all diabetic patients over 35 years
[7, 8] and must be performed in high-risk cardiovascu-
lar patients based on one of the following criteria [5,
7]: (1) age Q35 years or age Q25 years with a history of
type II DM diagnosed more than 10 years earlier, (2)
presence of any additional risk factors for coronary
artery disease, (3) presence of microvascular diseases
(retinopathy, nephropathy, microalbuminuria), periph-
eral vascular disease, or autonomic neuropathy.
Moreover, this test is used to define exercise
intensity, duration, and frequency as well as other
modalities of the training program.
The monitoring of blood glucose concentration
before, during, and after any acute exercise is consid-
ered a necessary procedure to prevent unpleasant
situations (Table 4). Blood glucose ranging from 150–
249 mg/dl is considered a safe amount for practicing
exercise [7, 28]. If these levels exceed 250 mg/dl,
exercise is contraindicated. Immediately after exercise,
patients should monitor blood glucose to prevent low
concentrations (lower than 70 mg/dl). In fact, one of
the most common causes of low blood glucose is the
exaggerated practice of physical activity. To prevent
low blood glucose or even hypoglycemia, diabetic
patients should avoid hot environments, like saunas
or steam rooms immediately after exercise, as these
favor the maintenance of an increased metabolic rate
and may be responsible for lower blood glucose.
Patients should also avoid the consumption of alcohol
before or immediately after exercise, as well as
exercising at the peak of insulin action [12]. Although
exercise-induced hypoglycemia is a less common
problem in type II DM than in type I DM, the risk is
increased in patients who are using insulin [15].
Changes in dosage or in the timing of insulin admin-
istration, as well as modifications, in meal habits are
usually efficient procedures to correct the problem.
A standard recommendation of the American
Diabetes Association and the American College of
Sports Medicine for diabetic patients includes a warm
up and a cool down period that should consist of 5–10
min of aerobic activity at low intensity, as well as a
stretching period [7]. The aim of the warm up session
is to prepare skeletal muscle and the cardiovascular
and respiratory systems for a progressive increase in
exercise intensity, and the cool down period allows a
gradual adjustment to baseline of heart rate and blood
pressure [7]. Stretching should be performed for 5–10
Table 4 Summary of preexercise blood glucose values (adapted




>300 Do not exercise on that day
250–299 Exercise must be done with caution; if
blood glucose rises after 10 min of
exercise, exercise must be stopped.
150–249 Safe levels for exercise
100–149 Be alert for signs and symptoms of
hypoglycemia.
<100 No exercise
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min, especially in muscles used during the training
session. It is important for DM patients to prevent foot
blisters by use of adequate socks and appropriate
shoes; any potential damage to their feet must be
monitored before and after any exercise session.
Because dehydration can affect blood glucose levels
and cardiovascular function, it is recommended to
ingest 500 ml of fluid until 2 h before starting the
exercise. During exercise, the fluid ingestion should
compensate all losses taking place by sweat and
ventilation, to avoid a loss of bodyweight at the end
of acute exercise [7].
Exercise recommendation for type II diabetic patients
Exercise programs for diabetic patients should consist
of aerobic endurance exercise, which enhances cardio-
respiratory fitness, muscular strength, and endurance,
and modifies body composition. However, in patients
with type II DM, this type of training together with
resistance training, as opposed to aerobic training
alone, seems to induce better positive adaptations of
glucose control, insulin function, muscular strength,
and exercise tolerance [29, 42]. Nevertheless, resis-
tance exercise or exercise performed at high intensities
should only be carried out by individuals without any
DM-associated chronic complications, such as prolif-
erative retinopathy or hypertension [2, 7, 14, 40].
Table 5 describes the exercise components recom-
mended for type II DM patients. To achieve cardiore-
spiratory and metabolic improvements, the exercise
intensity must be individually adjusted from low to
moderate, in correspondence to 40–70% of maximum
oxygen consumption [17, 34, 43]. The use of heart rate
for monitoring exercise intensity may not be suitable in
patients with type II DM because they may develop
autonomic neuropathy, which affects the heart rate
response to exercise [2, 14, 40]. Intensity should rather
be estimated using ratings of perceived exertion
(RPE), with recommended RPE of 10–16 (very light
to hard). The duration of exercise is directly related to
the caloric expenditure required and is inversely
related to the intensity. At least 30 min of continuous
and moderate exercise should be performed in each
training session. If weight loss is the main target of
exercise, its intensity needs to be set from low to
moderate (50% VO2 max), and the duration needs to
be increased up to 60 min.
To improve cardiovascular performance, the recom-
mended frequency of exercise is between three and
five sessions per week. Moreover, obese diabetic
patients may need to participate in daily physical
activity to maximize caloric expenditure for effective
weight management. Normally, patients with type II
DM are elderly, showing a decline in muscle mass
associated with a reduction in metabolic function.
Resistance training programs increase muscle strength
and muscle mass. Patients, however, with blood
glucose higher than 300 mg/dl, congestive heart failure,
uncontrolled arrhythmias, severe valvular malfunction,
or an aerobic capacity lower than five MET, are not
allowed to perform this type of training [14, 15, 34, 40,
52].
Resistance training should be performed at low
intensity [40–50% of 1 repetition maximum (RM)],
with 10–15 repetitions for each muscle group and a 3:1
ratio of endurance/resistance sessions [15, 28]. Low
intensity is suggested to avoid exaggerated blood
pressure. In the same way, regular breathing during
exertion can also prevent a severe rise in cardiac
afterload. The type of weightlifting equipment that
could be used depends on the patients_ preferences
and abilities [28].
There are several safe forms of exercise such as
walking, jogging, bicycling, and swimming, which allow
patients to maximize their caloric expenditure and to
improve physical fitness enjoyably and effectively.
Long-term exercise programs are usually accompanied
by a dropout rate of 90% of the initial participants
after 1 year[15], while in short-term exercise programs,
dropout rates range from 35–80% during the first 3–6
Table 5 Exercise characteristics recommended for type II DM patients (based on data from the American Diabetes Association [7],
Eriksson [15], Leutholtz and Ripoll [28], and Peirce [34])
Type Duration Frequency Intensity
Aerobic exercise such as walking,
running, bicycling, swimming




40–60% VO2 max or RPE 10–16 or 50–
70% of maximum heart rate
90 min/week >60% VO2 max or >70% of maximum
heart rate
Resistance 10–15 repetitions 2 days a week 40–50% of 1 RM
Warm up/cool down 5–10 min Before and
after exercise
Low intensity
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months [27]. Many reasons could contribute to refrain-
ing from maintenance of exercise, including lack of
time, travel problems, expenses, and injury, but waning
motivation seems to be the main cause [31]. Setting of
personal goals for individuals is necessary, both for the
DM patients and staff involved in the program,
because both are equally important in providing
encouragement to continue exercising. Even though
participation in regular exercise programs may be low,
a good strategy to maintain patients_ involvement in
such programs can be enhanced by routine activities of
daily living. Lifestyle modifications such as stair
climbing instead of using an elevator, household tasks,
and gardening can provide appropriate physical activ-
ity with increased calorie burning [15].
Exercise recommendations to patients with DM
complications
Type II DM is closely associated with obesity, dyslipi-
demia, and hypertension, which are important risk
factors for micro- and macrovascular diseases.
Concerning the prevalence of complications, at least
72% of patients have at least one complication; 19%
only have a microvascular complication, such as
neuropathy (28%), renal damage (20%), or retinopa-
thy (20%), and 10% of the patients have only a
macrovascular complication, which could be peripher-
al vascular disease (18%), angina (17%), heart failure
(12%), and myocardial infarction (9%) [33] (see Table
6). In people with DM, the persistently prolonged high
blood-glucose concentration may cause peripheral
neuropathy, which affects the limb nerves, which
supply the muscles, vessels, and skin of the feet, legs,
hands, and arms. The related symptoms may include
numbness or loss of sensation, tingling, coldness,
burning pain, hypersensitivity to touch, and problems
in balance or coordination. One might therefore
consider non-weight-bearing exercise in these cases.
Because repetitive exercise on hyposensitive feet can
lead to or aggravate an existent foot ulcer, the practice
of weight-bearing exercise should be restricted. The
use of well-fitted shoes and a daily foot examination
are also important measures for preventing this kind of
injury [7, 34, 40]. The occurrence of autonomic
neuropathy usually affects several organs and func-
tional systems like cardiovascular, digestion, tempera-
ture regulation, and sexual functions. The symptoms
depend on the nerve affected, e.g., incomplete bladder
emptying, stomach and bowel problems, orthostatic
hypotension, or sweating. The presence of an auto-
nomic neuropathy increases the risk of a cardiovascu-
lar crisis during exercise because patients with this
condition may experience a silent ischemia without
chest pain. An exercise program designed for type II
diabetes with autonomic neuropathy should avoid
exercise in hot and cold environments and should
require adequate fluid replacement, as this usually
influences thermoregulation [7, 34, 40]. In diabetic
nephropathy, exercise intensity should be relatively
low due to a potentially reduced overall exercise
capacity.
The prevalence of diabetes retinopathy appears to
vary with the age of onset and duration of the disease.
Retinopathy lesions could be divided into two large
categories: simple and proliferative. Part of the 10–
18% of patients with simple retinopathy will eventual-
ly progress to the proliferative form within a 10-year
period. About half of patients with proliferative
retinopathy will become blind within 5 years [8, 17].
Patients with active proliferative diabetes retinopathy,
Table 6 Major DM complications with clinical manifestations and exercise recommendations (adapted from the American Diabetes
Association [7], Sigal et al. [40], Vinik et al. [45], and Wilmore and Costil [51])
Clinical manifestations Exercise recommendation
Peripheral
neuropathy
Numbness, tingling, coldness, burning pain, hypersensitivity
to touch




Incomplete bladder emptying, stomach and bowel problems,
orthostatic hypotension, sweating
Exercise stress test is necessary before
starting an exercise program.
Diabetic
retinopathy




Occurrence of chest pain Exercise stress test
Hypertension Blood pressure higher than 140/90 mmHg Breathing technique during resistance
exercise should be trained
Dyslipidemia Increased plasma levels of VLDL and TG, decreased plasma
level of HDL
Low intensity and prolonged exercise
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who perform strenuous exercise, may provoke a
vitreous hemorrhage or a traction retinal detachment.
Therefore, such patients should avoid anaerobic exer-
cise and physical activity that involves straining or
Valsalva maneuvers, as in weightlifting. Exercise must
be low-impact such as swimming, walking, and station-
ary cycling [7].
Cardiovascular disease is a major cause of mortality
in persons with diabetes. Approximately, 85% of
mortality in patients with type II diabetes is due to
ischemic heart diseases. Silent heart attacks can occur
in patients with DM because an autonomic neuropathy
can mask the symptom of chest pain usually associated
with myocardial ischemia [8, 34]. Hypertension, dysli-
pidemia, smoking, a family history of coronary disease,
and the presence of micro- or macroalbuminuria also
constitute risk factors [7, 51]. Graded exercise testing
should be performed before the prescription of a
training program.
Blood pressure higher than 140/90 mmHg is a major
risk factor for the development of cardiovascular
diseases and microvascular complications that normal-
ly occur in over 60% of patients with type II diabetes.
Hypertension is likely to be present as part of the
metabolic syndrome. In general, physical exercise
associated with a diet aimed at reduced sodium intake,
reductions in bodyweight, avoidance of excessive
alcohol consumption, and increasing activity levels
have proven to be effective in reducing blood pressure
[7, 14, 51]. Activities involving breath holding, such as
heavy resistance training, should be avoided unless the
patients have acquired a proper breathing technique
during such an activity. When weightlifting, it is
important to exhale during the most strenuous part of
the exercise and to inhale during the least, so that
excessive changes in blood pressure are less likely to
occur.
The occurrence of dyslipidemia increases the risk
factor of macrovascular diseases. In type II diabetes,
dyslipidemia is characterized by enhanced plasma
levels of triglyceride and also by decreased levels of
high density lipoprotein (HDL). This profile is often
called Bdiabetic dyslipidemia^ [6]. Regular physical
exercise can reduce the risk of developing a macro-
vascular disease by the improvement of the plasma
lipid profile [10, 28]. In fact, regular exercise seems to
be effective in reducing the level of triglycerides and
VLDL, while increasing HDL. Within the lipid profile,
LDL should be less than 130 mg/dl, TG less than 200
mg/dl, and HDL more than 45 mg/dl [21]. The
favorable reduction of triglycerides and lipoprotein
cholesterol in patients with type II diabetes accom-
panies weight loss.
Low-intensity exercise, at least five times per week,
1 h per session, and performed continuously during 1
year, can reduce bodyweight. Weight loss also leads to
a decrease in insulin resistance [7, 51].
Platelet dysfunction associated with dyslipidemia
reveals a pattern of coagulation factors that increases
coagulation, while on the other hand, decreases
thrombolysis. In this case, platelet dysfunction could
favor atherosclerosis and vascular thrombosis. Impair-
ment in plasma fibrinolytic activity and tissue plasmin-
ogen activator activity, when plasminogen activator
inhibitor-1 activity is increased, induces both throm-
bosis and defective dissolution of a clot once formed.
Platelets in type II diabetes patients adhere to the
endothelium because of insufficient generation of
prostacyclin (PGI2) and nitric oxide (NO) by the
vascular endothelium. Consequently, vasoconstriction
and platelet aggregation could occur more rapidly than
in healthy people. Insulin, by sensitizing the platelet to
PGI2, is a natural antagonist of platelet hyperactivity,
and in addition, it enhances the endothelial generation
of PGI2 and NO. Thus, defects in insulin action in
diabetes create a disordered platelet activity. Aspirin
can block thromboxan synthesis by acetylation of the
platelet cyclooxygenase and may be used to prevent
cardiovascular disease in diabetic and nondiabetic
patients [3, 45].
Concluding remarks
Aerobic exercise and resistance exercise are recom-
mended for diabetic patients and must be individually
adjusted to the physiological and metabolic limitations
of each patient. Regular physical exercise and strength
training encourage positive adaptations in the control
of blood glucose concentration, insulin action, muscu-
lar strength, and exercise tolerance in patients with
type II diabetes. However, to produce beneficial
effects, exercise must be performed at a low intensity
and duration (40–60% VO2 max for at least 150 min/
week). Blood glucose should be monitored before and
after exercise to prevent hypoglycemia. Fluid replace-
ment is recommended before, during, and after
exercise. On the other hand, before starting an
exercise program, a medical examination is necessary
to identify diabetes-related complications affecting
cardiovascular function, which may be aggravated by
an exercise program. Nevertheless, lifestyle modifica-
tions including diet control coupled with physical
regular exercise are important for successfully achiev-
ing glycemic control.
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